The management of insulin resistance in polycystic ovary syndrome.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanLifestyle changes in women with polycystic ovary syndromeLifestyle changes in women with polycystic ovary syndromeMetformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysisContraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome PatientsRetinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Polycystic ovary syndrome and weight management.Exercise therapy in polycystic ovary syndrome: a systematic review.Is foetal hyperexposure to androgens a cause of PCOS?Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age.Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile.Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring.Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis.Assessment of insulin resistance in Chinese PCOS patients with normal glucose tolerance.Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity.Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome.Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
P2860
Q21245262-FA0CBED0-6AFE-4BD5-BDF6-1B559E2D395BQ24234000-7ACF0FF8-614D-4B96-9645-898FD3B15E04Q24235398-2D82A522-D055-4583-A8DE-8BAF88CAC1BDQ28088433-44E05123-4C30-4F5A-94EF-0A71A1DB8585Q30759526-D492B86E-585C-4795-8501-61ADC0B2503AQ34099068-F5297DBD-21E2-431F-AB92-64A9DB846D42Q35749412-36595028-6722-4776-AE4F-C65CD8CF7F58Q36192589-F1E24169-5BF1-4563-9AB6-3D61EBFE2807Q36756764-97F94206-EC7F-4D5F-8225-D7A3A5374350Q36903013-53057A21-B898-405B-9CD4-3DD8B91A2144Q37412812-9F5BE074-2D97-4C95-8DF0-A6A076476E5CQ37699367-114C6A93-EF9F-428E-B9C2-128714734EADQ37787632-BF31CB0B-52EE-41C3-95A1-D6DC42EBC25DQ38771084-B9AE0F12-B7A0-4DCE-A5B5-64A5910D3D87Q39026021-EA99CE86-7D1A-4DBD-BD62-77092AED72A2Q42852924-CD2ED41F-36E5-439C-A26B-158F05CAA816Q42993154-000ECC0A-D9AB-440B-B3C4-E76598E9EBE4Q43820575-96F04646-1F4B-45DD-A2AE-F6F3D0C11982Q44578117-3FE454CA-D5FC-40A7-8F49-15D6A711CAA1Q47225779-3629474F-080A-41A7-A2C1-BCE2998D015FQ50000272-AB7B7F16-8041-4176-9AD1-31A8B34498C1Q50546791-FE181C76-A044-43F2-B835-10B0602BAC63Q50628402-09242D3A-DFBC-4C8C-AB8B-5EB63C61D7C3Q50654959-F0C30322-6562-4B10-9232-00FD14DA40B0Q50880365-5434D7C0-C32A-4E54-9469-870648EE16A5Q50975570-5AF60500-C8BE-45BD-9EFD-0046A534FDFBQ51360494-75C4098A-7E59-4215-AC5A-993BAACDACD5Q53798125-E104ED09-396B-4C94-9044-F56B3E0B4733
P2860
The management of insulin resistance in polycystic ovary syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The management of insulin resistance in polycystic ovary syndrome.
@en
type
label
The management of insulin resistance in polycystic ovary syndrome.
@en
prefLabel
The management of insulin resistance in polycystic ovary syndrome.
@en
P2093
P1476
The management of insulin resistance in polycystic ovary syndrome.
@en
P2093
Helena J Teede
Samantha K Hutchison
Sophia Zoungas
P304
P356
10.1016/J.TEM.2007.08.001
P577
2007-08-16T00:00:00Z